Search clinical trials for: Fenofibrate/Simvastatin

Total 780 results

Abbott

Completed

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Dyslipidemia

Argentina, Czech Republic, Germany, Mexico, Poland, Romania, Russian Federation
Intermountain Health Care, Inc.
Merck Sharp & Dohme LLC; Abbott

Completed

Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study

Type II Diabetes Mellitus | Mixed Dyslipidemia

United States
Solvay Pharmaceuticals

Completed

Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

Hyperlipidemia

Czech Republic, Denmark, France, Germany, Hungary, Netherlands, Poland, Ukraine
Solvay Pharmaceuticals

Completed

Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

Cardiovascular Diseases

Australia, Estonia, Hungary, Latvia, Lithuania, New Zealand
Solvay Pharmaceuticals

Completed

Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin

Hyperlipidemia

Greece, Israel, Romania, Russian Federation, South Africa
Solvay Pharmaceuticals

Completed

Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin

Hyperlipidemia

Bulgaria, Czech Republic, Germany, Slovakia, Ukraine
Medical University of Warsaw
Children's Memorial Health Institute, Poland

Recruiting

Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes. (PRIFEN)

Diabetes Mellitus, Type 1

Poland
Novartis

Completed

Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

Dyslipidemia

Germany, Switzerland
Medical University of Silesia

Unknown

The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines (MSF)

Inflammation | Diabetes | Dyslipidemia | Cytokines

Poland
Alaa Hassan ElBaz

Unknown

Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients

Diabetic Retinopathy
Cairo University

Completed

Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis

Fenofibrate/Simvastatin Comparison
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions

Healthy
Koval' O., MD

Unknown

Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome

Diabetes Mellitus, Type 2 | Acute Coronary Syndrome | Hypertriglyceridemia

Ukraine
Gachon University Gil Medical Center

Completed

Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate

Hypertriglyceridemia

Korea, Republic of
Juan A. Arnaiz

Completed

Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding

Cirrhosis | Hypertension, Portal | Portal Vein Thrombosis | Bleeding Esophageal Varices

Spain
Tel-Aviv Sourasky Medical Center

Unknown

Simvastatin Treatment of Pachyonychia Congenita

Pachyonychia Congenita
Zhejiang University

Completed

Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia

Hyperlipoproteinemia

China
GlaxoSmithKline

Completed

Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension

Hypertriglyceridemia
Vejle Hospital

Completed

The Effect of High Dose Simvastatine on Multiple Myeloma

Multiple Myeloma
Merck Sharp & Dohme LLC

Completed

Fenofibrate Bioequivalence Study (0767-031)

Dyslipidemia
University of Copenhagen

Completed

Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being (LIFESTAT)

Cardiovascular Disease | Diabetes Mellitus

Denmark
Aegerion Pharmaceuticals, Inc.

Completed

Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents

Healthy

United States
University of Miami
University of Florida

Terminated

Pilot Study of Fenofibrate for PSC

Primary Sclerosing Cholangitis

United States
University of Pennsylvania
Abbott

Completed

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

Metabolic Syndrome x

United States
University of Michigan
Abbott

Completed

Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis

Hypertriglyceridemia With the Metabolic Syndrome

United States
Beijing Chao Yang Hospital

Unknown

Evaluate the Efficacy of Fenofibrate on Microalbuminuria

Microalbuminuria
Kaiser Permanente

Completed

Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy

Hyperlipidemias

United States
National Heart Institute, Mexico

Completed

Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease

Coronary Heart Disease | Hyperlipidemia

Mexico
VA Office of Research and Development

Terminated

Insulin Resistance in Non-alcoholic Fatty Liver Disease

Fatty Liver

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions

Healthy
Vanderbilt University
National Institutes of Health (NIH)

Completed

The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

Hypertension

United States
National Institute on Aging (NIA)

Unknown

Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function (PPAR)

Cardiovascular Diseases

United States
Washington University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Completed

Lipid Biomarkers for Diabetic Heart Disease

Diabetes Complications | Type II Diabetes Mellitus

United States
Gachon University Gil Medical Center

Completed

Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

Hypertriglyceridemia

Korea, Republic of
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males With Klinefelter Syndrome

Klinefelter Syndrome

United States
GlaxoSmithKline

Completed

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Dyslipidaemias

United States, Canada
National Institute of Diabetes and Digestive and...
Shriners Hospitals for Children

Completed

Substrate Cycling in Energy Metabolism

Burns | Insulin Resistance

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions

Healthy

India
Daiichi Sankyo, Inc.

Completed

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

Hypercholesterolemia | Hyperlipidemia, Familial Combined

United States
University of Florida
Shionogi Inc.; The PBCers Organization

Completed

Use of Fenofibrate for Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States
Mario Luca Morieri

Recruiting

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate (MAGNETIC)

Cardiovascular Diseases | Type 2 Diabetes | Pharmacogenomic Drug Interaction

Italy
Abbott
Rundo International Pharmaceutical Research & Development Co.,Ltd.

Completed

A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic

Cardiovascular Diseases | Dyslipidemias | Hypertriglyceridemia

China
University of Miami
Mayo Clinic

Withdrawn

Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States
The University of Texas Medical Branch, Galveston
Shriners Hospitals for Children

Withdrawn

Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate

Burn
University of Campania "Luigi Vanvitelli"

Unknown

Treatment of Hyperlipidemia and Sexual Dysfunction

Sexual Dysfunction | Hyperlipidemia

Italy
US Department of Veterans Affairs

Terminated

Insulin Resistance in Non-alcoholic Fatty Liver Disease

Fatty Liver | Insulin Resistance

United States
University of Oxford
British Heart Foundation

Active, not recruiting

Oxford - Fibrates in Aortic Stenosis (OxFAST)

Aortic Valve Stenosis

United Kingdom
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions

Healthy

United States
University of Minnesota
Laval University

Completed

Fenofibrate and Pharmacogenetic Impact in Dyslipidemia (FPI)

Dyslipidemia

United States
University of Oxford
University of Edinburgh; National Institute for Health Research, United Kingdom and other collaborators

Completed

Lowering Events in Non-proliferative Retinopathy in Scotland (LENS)

Diabetic Retinopathy

United Kingdom

Search clinical trials for: Fenofibrate/Simvastatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations